CPT1B expression was significantly higher in the narcolepsy patients than in the controls, and acylcarnitine levels were abnormally low in 21% of the narcolepsy patients while those of all the controls were within the normal range, suggesting that fatty acid β-oxidation is altered in narcolepsy [17]. The gene discussed is CPT1B; the disease is narcolepsy.